SlideShare una empresa de Scribd logo
1 de 65
Large vessel  Arteritis
Large Vessel Arteritis ,[object Object],[object Object]
Important points on GCA ,[object Object],[object Object],[object Object]
History of GCA ,[object Object],[object Object],[object Object],[object Object],[object Object]
Giant cell arteritis ,[object Object],[object Object]
Classification criteria GCA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Epidemiology ,[object Object],[object Object],[object Object],[object Object],[object Object]
Epidemiology contd ,[object Object],[object Object],[object Object],[object Object],[object Object]
Immunogenetics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Immunopathogenesis ,[object Object],[object Object],[object Object],[object Object]
Mechanism of arterial injury ,[object Object],[object Object],[object Object],[object Object]
Arterial injury ,[object Object],[object Object],[object Object]
Animal model of GCA ,[object Object],[object Object],[object Object],[object Object],[object Object]
Circulating cytokines in GCA ,[object Object],[object Object]
Biopsy positivity and GCA ,[object Object],[object Object],[object Object],[object Object],[object Object]
Anti-phospholipid and GCA ,[object Object],[object Object],[object Object],[object Object]
Pathogenesis of GCA ,[object Object],[object Object]
Pathology ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
Clinical features ,[object Object],[object Object],[object Object],[object Object],[object Object]
Visual involvement ,[object Object],[object Object],[object Object],[object Object]
Large arterial involvement ,[object Object],[object Object],[object Object]
Relation between GCA and PMR ,[object Object],[object Object],[object Object],[object Object]
Investigations ,[object Object],[object Object],[object Object],[object Object]
Imaging ,[object Object],[object Object],[object Object],[object Object],[object Object]
Mimics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment of GCA ,[object Object],[object Object],[object Object],[object Object],[object Object]
Treatment contd ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Methotrexate in GCA ,[object Object],[object Object],[object Object]
Takayasu definition ,[object Object]
 
Takayasu’s  vs  GCA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Epidemiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Epidemiology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pathology ,[object Object],[object Object],[object Object]
Pathogenesis ,[object Object],[object Object],[object Object],[object Object]
Clinical Features ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
GEOGRAPHICAL VARIATION OF AFFECTED VESSELS 38 52 8 Renal 65 22 11 Abdominal aorta 58 7 20 Common carotid 98 38 68 Aortic arch& branches NORTH AMERICA INDIA JAPAN
TAKAYASU CLASSIFICATION 1  Aortic arch 2a  1+ As Aorta 2b  2a+ thoracic aorta 3  Thoracic+ Abdominal aorta 4  Abdominal aorta 5  Entire aorta
TAKAYASU ACR criteria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Takayasu  Sharma  criteria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Takayasu- Uppal et al
Imaging ,[object Object],[object Object],[object Object]
Differential Diagnosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Disease groups based on complications ,[object Object],[object Object],[object Object],[object Object]
Takayasu - Outcome  ,[object Object],[object Object],[object Object],[object Object]
Treatment ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Response to Rx & Prognosis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PTCA & surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Settings for suspicion of Early Takayasu’s ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Guidelines for prescribing of bisphosphonates in patients on corticosteroids ,[object Object],[object Object],[object Object]
PREVENTION OF STEROID INDUCED OSTEOPOROSIS ,[object Object],[object Object],[object Object]
1. All patients on long term steroids should be given lifestyle advice: a)Adequate Calcium  (1000mg/d) and vitamin D (800units/d) intake b) Weight bearing exercise (20 minutes brisk walking daily) c) avoid tobacco and excess alcohol. 2. Patients who require steroid treatment with pred. at 7.5mg/day or more for 6 months or longer should have a bone density assessment using DEXA scanning. a) If DEXA result is Normal ie T score greater than –1.0, no other treatment is recommended.  b) If DEXA shows osteopaenia, ie T score between –1.0 and –2.5, then treatment should be started if there has been a previous low impact fracture. c) If DEXA shows osteoporosis, ie T score below –2.5, treatment should be started.
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
Settings for suspicion of Early Takayasu’s ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Guidelines for prescribing of bisphosphonates in patients on corticosteroids ,[object Object],[object Object]
PREVENTION OF STEROID INDUCED OSTEOPOROSIS ,[object Object],[object Object],[object Object]
1. All patients on long term steroids should be given lifestyle advice: a)Adequate Calcium  (1000mg/d) and vitamin D (800units/d) intake b) Weight bearing exercise (20 minutes brisk walking daily) c) avoid tobacco and excess alcohol. 2. Patients who require steroid treatment with pred. at 7.5mg/day or more for 6 months or longer should have a bone density assessment using DEXA scanning. a) If DEXA result is Normal ie T score greater than –1.0, no other treatment is recommended.  b) If DEXA shows osteopaenia, ie T score between –1.0 and –2.5, then treatment should be started if there has been a previous low impact fracture. c) If DEXA shows osteoporosis, ie T score below –2.5, treatment should be started.
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]

Más contenido relacionado

La actualidad más candente

aortoarteritis/takayasu,s
aortoarteritis/takayasu,saortoarteritis/takayasu,s
aortoarteritis/takayasu,s
Abhay Mange
 
Best practice in asymptomatic carotid stenosis
Best practice in asymptomatic carotid stenosisBest practice in asymptomatic carotid stenosis
Best practice in asymptomatic carotid stenosis
Pascual Lozano-Vilardell
 

La actualidad más candente (20)

Polyarteritis nodasa and microscopic polyangitis
Polyarteritis nodasa and microscopic polyangitisPolyarteritis nodasa and microscopic polyangitis
Polyarteritis nodasa and microscopic polyangitis
 
Takayasusarteritis
TakayasusarteritisTakayasusarteritis
Takayasusarteritis
 
Takayasu arteritis
Takayasu arteritis Takayasu arteritis
Takayasu arteritis
 
Takayashu arteritis
Takayashu arteritisTakayashu arteritis
Takayashu arteritis
 
aortoarteritis/takayasu,s
aortoarteritis/takayasu,saortoarteritis/takayasu,s
aortoarteritis/takayasu,s
 
Takayasu arteritis
Takayasu arteritis Takayasu arteritis
Takayasu arteritis
 
Takayasu Arteritis
Takayasu ArteritisTakayasu Arteritis
Takayasu Arteritis
 
Takayasu arteritis.fin al
Takayasu arteritis.fin alTakayasu arteritis.fin al
Takayasu arteritis.fin al
 
Coronary revascularization in diabetes mellitus and multivessel cad
Coronary revascularization in diabetes mellitus and multivessel cadCoronary revascularization in diabetes mellitus and multivessel cad
Coronary revascularization in diabetes mellitus and multivessel cad
 
Takayasu arteritis
Takayasu arteritisTakayasu arteritis
Takayasu arteritis
 
Lack of evidence in carotid stenosis
Lack of evidence in carotid stenosisLack of evidence in carotid stenosis
Lack of evidence in carotid stenosis
 
Contemporary management of iliofemoral venous thrombosis
Contemporary management of iliofemoral venous thrombosisContemporary management of iliofemoral venous thrombosis
Contemporary management of iliofemoral venous thrombosis
 
Takayasu arteritis
Takayasu  arteritisTakayasu  arteritis
Takayasu arteritis
 
LANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CADLANDMARK TRIALS IN STABLE CAD
LANDMARK TRIALS IN STABLE CAD
 
Best practice in asymptomatic carotid stenosis
Best practice in asymptomatic carotid stenosisBest practice in asymptomatic carotid stenosis
Best practice in asymptomatic carotid stenosis
 
Deep Vein Pathophysiology: Reflux & Obstruction
Deep Vein Pathophysiology: Reflux & ObstructionDeep Vein Pathophysiology: Reflux & Obstruction
Deep Vein Pathophysiology: Reflux & Obstruction
 
Thromboectomy trial
Thromboectomy trialThromboectomy trial
Thromboectomy trial
 
Revascularisation strategies
Revascularisation strategiesRevascularisation strategies
Revascularisation strategies
 
DVT PROPHYLAXIS IN ORTHOPAEDICS
DVT PROPHYLAXIS IN ORTHOPAEDICS DVT PROPHYLAXIS IN ORTHOPAEDICS
DVT PROPHYLAXIS IN ORTHOPAEDICS
 
Takayasu arteritis imaging
Takayasu arteritis imagingTakayasu arteritis imaging
Takayasu arteritis imaging
 

Similar a L A R Lecture

Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandip
Sandip Gupta
 
Aortic disasters ahmed
Aortic disasters ahmedAortic disasters ahmed
Aortic disasters ahmed
EM OMSB
 

Similar a L A R Lecture (20)

Takayasu arteritis
Takayasu arteritisTakayasu arteritis
Takayasu arteritis
 
Takayasu's arteritis
Takayasu's arteritisTakayasu's arteritis
Takayasu's arteritis
 
Takayasu arteritis case presentation
Takayasu arteritis case presentationTakayasu arteritis case presentation
Takayasu arteritis case presentation
 
Takayasu arteritis (case presentation)
Takayasu arteritis (case presentation)Takayasu arteritis (case presentation)
Takayasu arteritis (case presentation)
 
Atrial Fibrillation in Hypothyroidism
Atrial Fibrillation in HypothyroidismAtrial Fibrillation in Hypothyroidism
Atrial Fibrillation in Hypothyroidism
 
Uremic Pericarditis
Uremic PericarditisUremic Pericarditis
Uremic Pericarditis
 
03 msu disease of the vessels hajhamad m
03 msu disease of the vessels hajhamad m03 msu disease of the vessels hajhamad m
03 msu disease of the vessels hajhamad m
 
Samir rafla principles of cardiology pages 1 61 .. revised
Samir rafla principles of cardiology pages 1 61 .. revisedSamir rafla principles of cardiology pages 1 61 .. revised
Samir rafla principles of cardiology pages 1 61 .. revised
 
Takayasu_Arteritis_-_A_review_(1)[1].pptx
Takayasu_Arteritis_-_A_review_(1)[1].pptxTakayasu_Arteritis_-_A_review_(1)[1].pptx
Takayasu_Arteritis_-_A_review_(1)[1].pptx
 
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandip
 
NOMI
NOMINOMI
NOMI
 
Takayasu Arteritis, IgA Vasculitis ( Henoch Schonlein ) , Cryoglobulinemic va...
Takayasu Arteritis, IgA Vasculitis ( Henoch Schonlein ) , Cryoglobulinemic va...Takayasu Arteritis, IgA Vasculitis ( Henoch Schonlein ) , Cryoglobulinemic va...
Takayasu Arteritis, IgA Vasculitis ( Henoch Schonlein ) , Cryoglobulinemic va...
 
Acyanotic hd
Acyanotic hdAcyanotic hd
Acyanotic hd
 
Sub arachanoid heamorrhage
Sub arachanoid heamorrhageSub arachanoid heamorrhage
Sub arachanoid heamorrhage
 
Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)Gaint cell arteritiis (GCA)
Gaint cell arteritiis (GCA)
 
Congenital Cardiac Disease types and pathophysiology .ppt
Congenital Cardiac Disease types and pathophysiology .pptCongenital Cardiac Disease types and pathophysiology .ppt
Congenital Cardiac Disease types and pathophysiology .ppt
 
Aortic disasters ahmed
Aortic disasters ahmedAortic disasters ahmed
Aortic disasters ahmed
 
Kawasaki disease
Kawasaki diseaseKawasaki disease
Kawasaki disease
 
Inferior myocardial infarction
Inferior myocardial infarction Inferior myocardial infarction
Inferior myocardial infarction
 
2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt2.7. Cardiomyopathies_ lecture.ppt
2.7. Cardiomyopathies_ lecture.ppt
 

Más de drmomusa (20)

انتخابات المؤتمر الوطني العام
انتخابات المؤتمر الوطني العامانتخابات المؤتمر الوطني العام
انتخابات المؤتمر الوطني العام
 
beautiful_story
beautiful_storybeautiful_story
beautiful_story
 
Inflammatory Mediators Corrigan
Inflammatory Mediators    CorriganInflammatory Mediators    Corrigan
Inflammatory Mediators Corrigan
 
Fevers And Rheum Disease
Fevers And  Rheum  DiseaseFevers And  Rheum  Disease
Fevers And Rheum Disease
 
Zoledronic Acid Audit
Zoledronic Acid  AuditZoledronic Acid  Audit
Zoledronic Acid Audit
 
Vertebroplasty
VertebroplastyVertebroplasty
Vertebroplasty
 
Respiratory Complication Of Rheumatic Disease
Respiratory Complication Of Rheumatic DiseaseRespiratory Complication Of Rheumatic Disease
Respiratory Complication Of Rheumatic Disease
 
Arthritis
ArthritisArthritis
Arthritis
 
Ankle Sprain
Ankle  SprainAnkle  Sprain
Ankle Sprain
 
Trigger Finger
Trigger FingerTrigger Finger
Trigger Finger
 
Carpal Tunnel Syndrome
Carpal  Tunnel  SyndromeCarpal  Tunnel  Syndrome
Carpal Tunnel Syndrome
 
Research Governance Lecture
Research  Governance LectureResearch  Governance Lecture
Research Governance Lecture
 
Septic Arthritis Lyme Disease Lecture
Septic  Arthritis  Lyme Disease LectureSeptic  Arthritis  Lyme Disease Lecture
Septic Arthritis Lyme Disease Lecture
 
Out Come Of R
Out Come Of  ROut Come Of  R
Out Come Of R
 
Microb Immunity
Microb ImmunityMicrob Immunity
Microb Immunity
 
I Related Arthritis
I Related ArthritisI Related Arthritis
I Related Arthritis
 
Cases For S Teaching1
Cases For  S Teaching1Cases For  S Teaching1
Cases For S Teaching1
 
Metanalysis Lecture
Metanalysis LectureMetanalysis Lecture
Metanalysis Lecture
 
Scleroderma
SclerodermaScleroderma
Scleroderma
 
Carpometacarpal ( C)
Carpometacarpal ( C)Carpometacarpal ( C)
Carpometacarpal ( C)
 

L A R Lecture

  • 1. Large vessel Arteritis
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.  
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.  
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38. GEOGRAPHICAL VARIATION OF AFFECTED VESSELS 38 52 8 Renal 65 22 11 Abdominal aorta 58 7 20 Common carotid 98 38 68 Aortic arch& branches NORTH AMERICA INDIA JAPAN
  • 39. TAKAYASU CLASSIFICATION 1 Aortic arch 2a 1+ As Aorta 2b 2a+ thoracic aorta 3 Thoracic+ Abdominal aorta 4 Abdominal aorta 5 Entire aorta
  • 40.
  • 41.
  • 43.
  • 44.
  • 45.
  • 46.
  • 47.
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53. 1. All patients on long term steroids should be given lifestyle advice: a)Adequate Calcium (1000mg/d) and vitamin D (800units/d) intake b) Weight bearing exercise (20 minutes brisk walking daily) c) avoid tobacco and excess alcohol. 2. Patients who require steroid treatment with pred. at 7.5mg/day or more for 6 months or longer should have a bone density assessment using DEXA scanning. a) If DEXA result is Normal ie T score greater than –1.0, no other treatment is recommended. b) If DEXA shows osteopaenia, ie T score between –1.0 and –2.5, then treatment should be started if there has been a previous low impact fracture. c) If DEXA shows osteoporosis, ie T score below –2.5, treatment should be started.
  • 54.
  • 55.
  • 56.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61. 1. All patients on long term steroids should be given lifestyle advice: a)Adequate Calcium (1000mg/d) and vitamin D (800units/d) intake b) Weight bearing exercise (20 minutes brisk walking daily) c) avoid tobacco and excess alcohol. 2. Patients who require steroid treatment with pred. at 7.5mg/day or more for 6 months or longer should have a bone density assessment using DEXA scanning. a) If DEXA result is Normal ie T score greater than –1.0, no other treatment is recommended. b) If DEXA shows osteopaenia, ie T score between –1.0 and –2.5, then treatment should be started if there has been a previous low impact fracture. c) If DEXA shows osteoporosis, ie T score below –2.5, treatment should be started.
  • 62.
  • 63.
  • 64.
  • 65.